Compare Cipta Sarana Medika Tbk. (DKHH) vs Tripar Multivision Plus Tbk. (RAAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Tripar Multivision Plus Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp65 (market cap 160.67B, 19.95M 24h volume), while Tripar Multivision Plus Tbk. trades at Rp208 (market cap 1.36T, 895.9K 24h volume). The key difference: Tripar Multivision Plus Tbk. is far larger — about 8.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (19.95M versus 895.9K). Which is the better fit depends on your goals.
| DKHH | RAAM | |
|---|---|---|
Market Cap | 160.67B | 1.36T |
Volume | 19.95M | 895.9K |
Lot | 199.54K | 8.96K |
Turnover | 1.3B | 184.08M |
Average Price | 65.32 | 205.47 |
Value | 1.3B | 184.08M |
Indicative Equilibrium Price | 64 | 202 |
Indicative Equilibrium Volume | 1.35K | 2 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →
